Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Judit Riera-Arnau

6PUBLICATIONS

32CO-AUTHORS

Immunogenetics (incl. genetic immunology)Query processing and optimisationPharmacogenomicsPredictive and prognostic markersInstrumental methods (excl. immunological and bioassay methods)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Mar 28, 2026

Immunocompromised Status Definition in Observational Studies Using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm.

Judit Riera-Arnau, Nicoletta Luxi, Fabio Riefolo

|Jan 13, 2025

INSIGHT: A Tool for Fit-for-Purpose Evaluation and Quality Assessment of Standardized Observational Data Sources for Real World Evidence on Medicine and Vaccine Safety.

Vjola Hoxhaj, Constanza L Andaur Navarro, Judit Riera-Arnau

|Feb 12, 2024

COVID-19 and pregnancy: A European study on pre- and post-infection medication use.

Eimir Hurley, Benjamin P Geisler, Angela Lupattelli

|Oct 27, 2022

Use of chronic medications and risk of death due to COVID-19 in hospitalised patients.

María Larrosa-García, Sonia Garcia-Garcia, Javier Louro

|Jan 26, 2022

Application of pharmacovigilance tools in a case of subacute anterior angle narrowing while under furosemide exposure.

Emilie Anderssen-Nordahl, Judit Riera-Arnau, Manel Perelló Carrascosa

|Nov 10, 2020

Patients' contribution to drug safety in Catalonia: the interest of personal feelings on adverse drug reactions.

J Riera-Arnau, L A Alvarado Aguirre, N Garcia Doladé

Pageof 1

Frequent Collaborators

2 joint publications

Miriam C J M Sturkenboom

2 joint publications

Elena Ballarín

1 joint publications

Emilie Anderssen-Nordahl

1 joint publications

Sonia Garcia-Garcia

1 joint publications

Eimir Hurley

1 joint publications

Benjamin P Geisler

1 joint publications

Angela Lupattelli

1 joint publications

Beatriz Poblador-Plou

1 joint publications

Gabriel Sanfélix-Gimeno

1 joint publications

Francisco Sánchez-Saez

Frequent Collaborators

2 joint publications

Miriam C J M Sturkenboom

2 joint publications

Elena Ballarín

1 joint publications

Emilie Anderssen-Nordahl

1 joint publications

Sonia Garcia-Garcia

Top Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on : Jan 08, 2020

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases

Published on : Oct 24, 2019

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on : Feb 28, 2025

See more related videos

Top Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on : Jan 08, 2020

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases

Published on : Oct 24, 2019

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on : Feb 28, 2025

See more related videos